title: [Smoothing Gan Reinforcing Shen Method Adjuvantly Treated Poor Response of Diminished Ovari- an Reserve Patients in in vitro Fertilization and Embryo Transfer: a Clinical Study].
abstract: OBJECTIVE
  To study clinical efficacy of smoothing Gan reinforcing Shen (SGRS) method in treating poor response of diminished ovarian reserve (DOR) patients in in vitro fertilization and embryo, transfer (IVF-ET).
  
  
  METHODS
  Totally 84 DOR patients undergoing IVF-ET were assigned to the experimental group (SGRS Chinese herbs as adjuvant therapy) and the control group according to random digit table, 42 in each group. Patients in the control group received controlled ovarian hyperstimulation (COH) and IVF-ET. Those in the experimental group additionally received basic formula of SGRS method, one dose per day. The dose and use time of recombinant follicle-stimulating hormone (r-FSH) were recorded during ovarian stimulation process. On the injection day of human chorionic gonadotropin (HCG) and serum levels of estradiol (E2) on the oocyte retrieval day were determined using chemiluminescent method. E2 contents in the follicular fluid on the oocyte retrieval day were detected using ELISA. The total number of retrieved oocytes, the number of mature oocytes in metaphase II (M II), the number of normal fertilization [with two pronucleus (2PN)], the number of portable embryos, and the number of good quality embryos were recorded. The correlation between Chinese medical adjuvant therapy and the aforesaid indices were observed. The clinical pregnancy rate and the abortion rate were finally compared between the two groups.
  
  
  RESULTS
  The total dose of r-FSH, the E2 level on HCG injection day, the serum E2 level on the oocyte retrieval day, the number of retrieved oocyte, the number of oocytes in M II the number of oocytes with 2PN, the number of portable embryos, and the number of good quality embryos were all positively correlated with Chinese medical adjuvant therapy (P < 0.05, P < 0.01). Compared with the control group, serum E2 levels on the HCG injection day and the oocyte retrieval day obviously increased, the number of retrieved oocytes, the number of oocytes in M II, and the number of portable embryos were increased more in the experimental group with statistical difference (P < 0.05, P < 0.01). There was no statistical significance in the clinical pregnancy rate or the abortion rate between the two groups (P > 0.05).
  
  
  CONCLUSIONS
  SGRS Chinese herbs as adjuvant therapy could improve ovarian responsiveness of DOR patients undergoing IVF-ET, increase the number of retrieved oocytes, elevate the quality of oocytes and the number of embryos.
authors.forename: Zheng
authors.initials: Z
authors.lastname: Zhang
authors.forename: Xue-hong
authors.initials: XH
authors.lastname: Zhang
authors.forename: Tian-you
authors.initials: TY
authors.lastname: He
mesh_terms: D000277:Adjuvants, Pharmaceutic / Q000627:therapeutic use; D006063:Chorionic Gonadotropin; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use; D004624:Embryo Transfer / Q000379:methods; D004958:Estradiol; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D005640:Follicle Stimulating Hormone / Q000378:metabolism / Q000627:therapeutic use; D015571:Follicular Fluid; D006801:Humans; D008516:Medicine, Chinese Traditional; D054315:Oocyte Retrieval; D009865:Oocytes; D016471:Ovarian Hyperstimulation Syndrome; D010062:Ovulation Induction; D011247:Pregnancy; D018873:Pregnancy Rate
chemical_list: D000277:Adjuvants, Pharmaceutic; D006063:Chorionic Gonadotropin; D004365:Drugs, Chinese Herbal; D004958:Estradiol; D005640:Follicle Stimulating Hormone